Morphosis Capital
About
Morphosis Capital Morphosis Capital was founded in 2018 by four Romanian entrepreneurs as a CEE SME- focused PE firm. Fund II closed at €130M (oversubscribed), backed by EIF, EBRD, and IFC. Check sizes run €10-15M targeting companies with €1-5M EBITDA. The portfolio of 8 companies has €197M in combined 2023 turnover and 1,500 jobs. The deep tech highlight is EnduroSat. a leading European nanosatellite provider. Other portfolio companies include DocProcess (exited), Medima Health, EMI, Cronos Me
Industries
Stage focus
Series ASeries B+
Geography
Europe
Notable investments
- EnduroSat
Raising from Morphosis Capital?
I've worked with founders across the industrial stack. If Morphosis Capital is on your list, I can help you map the introduction path, sharpen the narrative, and run a tight process.
Talk to Dan